MedDataX Logo

Evaluate the Role of a Personalized Smartphone Based Application to Improve Childhood Immunization Coverage

NCT04449107 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 328

Last updated 2020-06-26

No results posted yet for this study

Summary

The vision of the investigators is to build capacity in technology-driven healthcare innovation in LMCIs. The programme will be initiated by a feasibility and proof-of-concept (POC) study to tackle the lack of awareness around immunization, which is a major health issue in developing countries. Mobile apps and social media have been shown to be effective in various programmes worldwide, but there is limited data from LMICs on the use of digital technologies in improving routine immunization (RI) coverage.

Conditions

  • Mobile Application
  • Routine Childhood Immunization

Interventions

BEHAVIORAL

Android based mobile phone application

An android based mobile application will be developed. The application will have features and capacity for text messages, voice messages, pictorial messages and video messages. The content of the messages will be according to the findings of Paigham e sehat project and the four messages domains would be educational, reminder, religious and adverse effects. In addition, pictorial and video messages would be used as per freely available through EPI programme Pakistan.

Sponsors & Collaborators

  • NED University of Engineering and Technology

    collaborator UNKNOWN

  • University of Surrey

    collaborator OTHER

  • Aga Khan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Weeks
Max Age
2 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-27
Primary Completion
2020-08-30
Completion
2020-12-31

Countries

  • Pakistan

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04449107 on ClinicalTrials.gov